NEXIEN BIOPHARMA, INC. Operating Income
NEXIEN BIOPHARMA, INC. reported Operating Income of -$11.64 million for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-05-14
- NEXIEN BIOPHARMA, INC. operating income (loss) for the quarter ending 2025-03-31 was -$30.09K, a 156.60% decline year-over-year.
- NEXIEN BIOPHARMA, INC. operating income (loss) for the quarter ending 2024-09-30 was -$23.10M, a 30934.98% decline year-over-year.
- NEXIEN BIOPHARMA, INC. operating income (loss) for the quarter ending 2024-06-30 was $86.51K.
- NEXIEN BIOPHARMA, INC. operating income (loss) for the quarter ending 2024-03-31 was $53.16K.
- NEXIEN BIOPHARMA, INC. operating income (loss) for fiscal 2021 was $10.31M, a 22.02% increase from fiscal 2020.
- NEXIEN BIOPHARMA, INC. operating income (loss) for fiscal 2020 was $8.45M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 15 month | Operating Income (Loss) 21 month | Operating Income (Loss) 24 month | Operating Income (Loss) 27 month | Operating Income (Loss) 30 month | Operating Income (Loss) 75 month | Operating Income (Loss) 78 month | Operating Income (Loss) 81 month | Operating Income (Loss) 84 month | Operating Income (Loss) 87 month | Operating Income (Loss) 90 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$30.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$11.64M 10-Q · filed 2025-05-14 | |||||||||||||
| 2024-12-31 | -$11.61M 10-Q · filed 2025-02-14 | ||||||||||||||
| 2024-09-30 | -$23.10M derived: 10-Q 90 month − 10-K 87 month · filed 2024-11-18 | -$23.01M derived: sum of 2 quarters · filed 2024-11-18 | -$22.96M derived: sum of 3 quarters · filed 2024-11-18 | -$22.94M derived: sum of 4 quarters · filed 2024-11-18 | -$11.57M 10-Q · filed 2024-11-18 | ||||||||||
| 2024-06-30 | $86.51K derived: 10-K 87 month − 10-Q 84 month · filed 2024-10-22 | $139.68K derived: sum of 2 quarters · filed 2024-10-22 | $164.19K derived: sum of 3 quarters · filed 2024-10-22 | $239.11K derived: sum of 4 quarters · filed 2024-10-22 | $11.53M 10-K · filed 2024-10-22 | ||||||||||
| 2024-03-31 | $53.16K derived: 10-Q 84 month − 10-Q 81 month · filed 2024-05-15 | $77.68K derived: sum of 2 quarters · filed 2024-05-15 | $152.60K derived: sum of 3 quarters · filed 2024-05-15 | $11.45M 10-Q · filed 2024-05-15 | |||||||||||
| 2023-12-31 | $24.52K derived: 10-Q 81 month − 10-Q 78 month · filed 2024-02-20 | $99.44K derived: sum of 2 quarters · filed 2024-02-20 | $11.39M 10-Q · filed 2024-02-20 | ||||||||||||
| 2023-09-30 | $74.92K derived: 10-Q 78 month − 10-K 75 month · filed 2023-11-14 | $11.37M 10-Q · filed 2023-11-14 | |||||||||||||
| 2023-06-30 | $11.30M 10-K · filed 2023-09-28 | ||||||||||||||
| 2021-09-30 | $10.43M 10-Q · filed 2021-11-22 | $10.61M derived: sum of 2 quarters · filed 2021-11-22 | $10.40M derived: sum of 3 quarters · filed 2021-11-22 | $11.23M derived: sum of 4 quarters · filed 2021-11-22 | |||||||||||
| 2021-06-30 | $181.69K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | -$29.51K derived: sum of 2 quarters · filed 2021-10-12 | $798.52K derived: sum of 3 quarters · filed 2021-10-12 | $10.31M 10-K · filed 2021-10-12 | |||||||||||
| 2021-03-31 | -$211.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-05 | $616.84K derived: sum of 2 quarters · filed 2021-05-05 | $10.13M 10-Q · filed 2021-05-05 | $10.80M derived: sum of 4 quarters · filed 2021-05-05 | |||||||||||
| 2020-12-31 | $828.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $10.34M 10-Q · filed 2021-02-11 | $11.01M derived: sum of 3 quarters · filed 2021-02-11 | $11.57M derived: sum of 4 quarters · filed 2021-02-11 | |||||||||||
| 2020-09-30 | $9.51M 10-Q · filed 2020-11-10 | $10.18M derived: sum of 2 quarters · filed 2020-11-10 | $10.74M derived: sum of 3 quarters · filed 2020-11-10 | $17.21M derived: sum of 4 quarters · filed 2020-11-10 | |||||||||||
| 2020-06-30 | $673.77K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-28 | $1.23M derived: sum of 2 quarters · filed 2020-09-28 | $7.71M derived: sum of 3 quarters · filed 2020-09-28 | $8.45M 10-K · filed 2020-09-28 | |||||||||||
| 2020-03-31 | $559.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14 | $7.03M derived: sum of 2 quarters · filed 2020-09-28 | $7.77M 10-Q · filed 2020-05-14 | $8.83M derived: sum of 4 quarters · filed 2020-09-28 | |||||||||||
| 2019-12-31 | $6.47M derived: 10-K 12 month − 3 quarters · filed 2020-09-28 | $7.21M 10-Q · filed 2020-02-12 | $8.27M derived: sum of 3 quarters · filed 2020-09-28 | $8.76M derived: sum of 4 quarters · filed 2020-09-28 | |||||||||||
| 2019-09-30 | $741.90K derived: 10-Q 30 month − 10-K 27 month · filed 2019-11-12 | $1.80M derived: sum of 2 quarters · filed 2019-11-12 | $2.29M derived: sum of 3 quarters · filed 2019-11-12 | $6.52M 10-Q · filed 2019-11-12 | |||||||||||
| 2019-06-30 | $1.06M derived: 10-K 27 month − 10-Q 24 month · filed 2019-09-30 | $1.54M derived: sum of 2 quarters · filed 2019-09-30 | $5.78M 10-K · filed 2019-09-30 | ||||||||||||
| 2019-03-31 | $484.81K derived: 10-Q 24 month − 10-Q 21 month · filed 2019-05-14 | $4.72M 10-Q · filed 2019-05-14 | |||||||||||||
| 2018-12-31 | $4.23M 10-Q · filed 2019-02-14 | ||||||||||||||
| 2018-06-30 | -$1.47M 10-K · filed 2018-09-28 | ||||||||||||||
| 2017-06-30 | $2.27M 10-Q · filed 2018-11-14 |